Analysis: Healthcare companies counter investor worries over Wegovy effect ...Middle East

TOP world News today - News
Analysis: Healthcare companies counter investor worries over Wegovy effect
A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. REUTERS/Jim Vondruska/Illustration/File Photo Acquire Licensing Rights Oct 27 (Reuters) – Healthcare companies who profit from treating obese and overweight patients are trying to convince investors that powerful new weight-loss drugs won’t shrink their businesses. The global market for obesity drugs could reach as much as $100 billion within a decade due to the effectiveness of Novo Nordisk’s (NOVOb.CO) Wegovy and similar medicines. Such forecasts have prompted a sell-off in a wide range of companies from makers of bariatric surgery devices

Hence then, the article about analysis healthcare companies counter investor worries over wegovy effect was published today ( ) and is available on TOP world News today ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Analysis: Healthcare companies counter investor worries over Wegovy effect )

Apple Storegoogle play

Last updated :

Also on site :



Latest News